 | • レポートコード：MRC2-11QY03851 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は運動ニューロン疾患治療のグローバル市場について調査・分析したレポートです。種類別（リルゾール、ヌシネルセン、理学療法、呼吸療法、その他）市場規模、用途別（総合クリニック、病院、ソーシャルワーク施設、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別運動ニューロン疾患治療の競争状況、市場シェア ・世界の運動ニューロン疾患治療市場：種類別市場規模 2015年-2020年（リルゾール、ヌシネルセン、理学療法、呼吸療法、その他） ・世界の運動ニューロン疾患治療市場：種類別市場規模予測 2021年-2026年（リルゾール、ヌシネルセン、理学療法、呼吸療法、その他） ・世界の運動ニューロン疾患治療市場：用途別市場規模 2015年-2020年（総合クリニック、病院、ソーシャルワーク施設、その他） ・世界の運動ニューロン疾患治療市場：用途別市場規模予測 2021年-2026年（総合クリニック、病院、ソーシャルワーク施設、その他） ・北米の運動ニューロン疾患治療市場分析：米国、カナダ ・ヨーロッパの運動ニューロン疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの運動ニューロン疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の運動ニューロン疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの運動ニューロン疾患治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：NIH、UCL Institute of Neurology、National Neuroscience Institute、The University of Melbourne、The University of Sheffield、OZBiosciences、The University of Queensland、MND Australia ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Motor Neuron Diseases Treatment Market
The global Motor Neuron Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Motor Neuron Diseases Treatment Scope and Market Size
Motor Neuron Diseases Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Motor Neuron Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
NIH
UCL Institute of Neurology
National Neuroscience Institute
The University of Melbourne
The University of Sheffield
OZBiosciences
The University of Queensland
MND Australia
Market segment by Type, the product can be split into
Riluzole
Nusinersen
Physical Therapy
Respiratory Therapy
Others
Market segment by Application, split into
Multidisciplinary Clinics
Hospitals
Social Work Facilities
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Motor Neuron Diseases Treatment Revenue
1.4 Market by Type
1.4.1 Global Motor Neuron Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Riluzole
1.4.3 Nusinersen
1.4.4 Physical Therapy
1.4.5 Respiratory Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Motor Neuron Diseases Treatment Market Share by Application: 2020 VS 2026
1.5.2 Multidisciplinary Clinics
1.5.3 Hospitals
1.5.4 Social Work Facilities
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Motor Neuron Diseases Treatment Market Perspective (2015-2026)
2.2 Global Motor Neuron Diseases Treatment Growth Trends by Regions
2.2.1 Motor Neuron Diseases Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Motor Neuron Diseases Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Motor Neuron Diseases Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Motor Neuron Diseases Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Motor Neuron Diseases Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Motor Neuron Diseases Treatment Players by Market Size
3.1.1 Global Top Motor Neuron Diseases Treatment Players by Revenue (2015-2020)
3.1.2 Global Motor Neuron Diseases Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Motor Neuron Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Motor Neuron Diseases Treatment Market Concentration Ratio
3.2.1 Global Motor Neuron Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Motor Neuron Diseases Treatment Revenue in 2019
3.3 Motor Neuron Diseases Treatment Key Players Head office and Area Served
3.4 Key Players Motor Neuron Diseases Treatment Product Solution and Service
3.5 Date of Enter into Motor Neuron Diseases Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Motor Neuron Diseases Treatment Historic Market Size by Type (2015-2020)
4.2 Global Motor Neuron Diseases Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Motor Neuron Diseases Treatment Market Size by Application (2015-2020)
5.2 Global Motor Neuron Diseases Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Motor Neuron Diseases Treatment Market Size (2015-2020)
6.2 Motor Neuron Diseases Treatment Key Players in North America (2019-2020)
6.3 North America Motor Neuron Diseases Treatment Market Size by Type (2015-2020)
6.4 North America Motor Neuron Diseases Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Motor Neuron Diseases Treatment Market Size (2015-2020)
7.2 Motor Neuron Diseases Treatment Key Players in Europe (2019-2020)
7.3 Europe Motor Neuron Diseases Treatment Market Size by Type (2015-2020)
7.4 Europe Motor Neuron Diseases Treatment Market Size by Application (2015-2020)
8 China
8.1 China Motor Neuron Diseases Treatment Market Size (2015-2020)
8.2 Motor Neuron Diseases Treatment Key Players in China (2019-2020)
8.3 China Motor Neuron Diseases Treatment Market Size by Type (2015-2020)
8.4 China Motor Neuron Diseases Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Motor Neuron Diseases Treatment Market Size (2015-2020)
9.2 Motor Neuron Diseases Treatment Key Players in Japan (2019-2020)
9.3 Japan Motor Neuron Diseases Treatment Market Size by Type (2015-2020)
9.4 Japan Motor Neuron Diseases Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Motor Neuron Diseases Treatment Market Size (2015-2020)
10.2 Motor Neuron Diseases Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Motor Neuron Diseases Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Motor Neuron Diseases Treatment Market Size by Application (2015-2020)
11 India
11.1 India Motor Neuron Diseases Treatment Market Size (2015-2020)
11.2 Motor Neuron Diseases Treatment Key Players in India (2019-2020)
11.3 India Motor Neuron Diseases Treatment Market Size by Type (2015-2020)
11.4 India Motor Neuron Diseases Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Motor Neuron Diseases Treatment Market Size (2015-2020)
12.2 Motor Neuron Diseases Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Motor Neuron Diseases Treatment Market Size by Type (2015-2020)
12.4 Central & South America Motor Neuron Diseases Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 NIH
13.1.1 NIH Company Details
13.1.2 NIH Business Overview
13.1.3 NIH Motor Neuron Diseases Treatment Introduction
13.1.4 NIH Revenue in Motor Neuron Diseases Treatment Business (2015-2020))
13.1.5 NIH Recent Development
13.2 UCL Institute of Neurology
13.2.1 UCL Institute of Neurology Company Details
13.2.2 UCL Institute of Neurology Business Overview
13.2.3 UCL Institute of Neurology Motor Neuron Diseases Treatment Introduction
13.2.4 UCL Institute of Neurology Revenue in Motor Neuron Diseases Treatment Business (2015-2020)
13.2.5 UCL Institute of Neurology Recent Development
13.3 National Neuroscience Institute
13.3.1 National Neuroscience Institute Company Details
13.3.2 National Neuroscience Institute Business Overview
13.3.3 National Neuroscience Institute Motor Neuron Diseases Treatment Introduction
13.3.4 National Neuroscience Institute Revenue in Motor Neuron Diseases Treatment Business (2015-2020)
13.3.5 National Neuroscience Institute Recent Development
13.4 The University of Melbourne
13.4.1 The University of Melbourne Company Details
13.4.2 The University of Melbourne Business Overview
13.4.3 The University of Melbourne Motor Neuron Diseases Treatment Introduction
13.4.4 The University of Melbourne Revenue in Motor Neuron Diseases Treatment Business (2015-2020)
13.4.5 The University of Melbourne Recent Development
13.5 The University of Sheffield
13.5.1 The University of Sheffield Company Details
13.5.2 The University of Sheffield Business Overview
13.5.3 The University of Sheffield Motor Neuron Diseases Treatment Introduction
13.5.4 The University of Sheffield Revenue in Motor Neuron Diseases Treatment Business (2015-2020)
13.5.5 The University of Sheffield Recent Development
13.6 OZBiosciences
13.6.1 OZBiosciences Company Details
13.6.2 OZBiosciences Business Overview
13.6.3 OZBiosciences Motor Neuron Diseases Treatment Introduction
13.6.4 OZBiosciences Revenue in Motor Neuron Diseases Treatment Business (2015-2020)
13.6.5 OZBiosciences Recent Development
13.7 The University of Queensland
13.7.1 The University of Queensland Company Details
13.7.2 The University of Queensland Business Overview
13.7.3 The University of Queensland Motor Neuron Diseases Treatment Introduction
13.7.4 The University of Queensland Revenue in Motor Neuron Diseases Treatment Business (2015-2020)
13.7.5 The University of Queensland Recent Development
13.8 MND Australia
13.8.1 MND Australia Company Details
13.8.2 MND Australia Business Overview
13.8.3 MND Australia Motor Neuron Diseases Treatment Introduction
13.8.4 MND Australia Revenue in Motor Neuron Diseases Treatment Business (2015-2020)
13.8.5 MND Australia Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Motor Neuron Diseases Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Motor Neuron Diseases Treatment Revenue
Table 3. Ranking of Global Top Motor Neuron Diseases Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Motor Neuron Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Riluzole
Table 6. Key Players of Nusinersen
Table 7. Key Players of Physical Therapy
Table 8. Key Players of Respiratory Therapy
Table 9. Key Players of Others
Table 10. Global Motor Neuron Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Motor Neuron Diseases Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Motor Neuron Diseases Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Motor Neuron Diseases Treatment Market Share by Regions (2015-2020)
Table 14. Global Motor Neuron Diseases Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Motor Neuron Diseases Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Motor Neuron Diseases Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Motor Neuron Diseases Treatment Players
Table 21. Global Motor Neuron Diseases Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Motor Neuron Diseases Treatment Market Share by Players (2015-2020)
Table 23. Global Top Motor Neuron Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motor Neuron Diseases Treatment as of 2019)
Table 24. Global Motor Neuron Diseases Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Motor Neuron Diseases Treatment Product Solution and Service
Table 27. Date of Enter into Motor Neuron Diseases Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Motor Neuron Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Motor Neuron Diseases Treatment Market Size Share by Type (2015-2020)
Table 31. Global Motor Neuron Diseases Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Motor Neuron Diseases Treatment Market Size Share by Application (2015-2020)
Table 33. Global Motor Neuron Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Motor Neuron Diseases Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Motor Neuron Diseases Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Motor Neuron Diseases Treatment Market Share (2019-2020)
Table 37. North America Motor Neuron Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Motor Neuron Diseases Treatment Market Share by Type (2015-2020)
Table 39. North America Motor Neuron Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Motor Neuron Diseases Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Motor Neuron Diseases Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Motor Neuron Diseases Treatment Market Share (2019-2020)
Table 43. Europe Motor Neuron Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Motor Neuron Diseases Treatment Market Share by Type (2015-2020)
Table 45. Europe Motor Neuron Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Motor Neuron Diseases Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Motor Neuron Diseases Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Motor Neuron Diseases Treatment Market Share (2019-2020)
Table 49. China Motor Neuron Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Motor Neuron Diseases Treatment Market Share by Type (2015-2020)
Table 51. China Motor Neuron Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Motor Neuron Diseases Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Motor Neuron Diseases Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Motor Neuron Diseases Treatment Market Share (2019-2020)
Table 55. Japan Motor Neuron Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Motor Neuron Diseases Treatment Market Share by Type (2015-2020)
Table 57. Japan Motor Neuron Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Motor Neuron Diseases Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Motor Neuron Diseases Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Motor Neuron Diseases Treatment Market Share (2019-2020)
Table 61. Southeast Asia Motor Neuron Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Motor Neuron Diseases Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Motor Neuron Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Motor Neuron Diseases Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Motor Neuron Diseases Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Motor Neuron Diseases Treatment Market Share (2019-2020)
Table 67. India Motor Neuron Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Motor Neuron Diseases Treatment Market Share by Type (2015-2020)
Table 69. India Motor Neuron Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Motor Neuron Diseases Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Motor Neuron Diseases Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Motor Neuron Diseases Treatment Market Share (2019-2020)
Table 73. Central & South America Motor Neuron Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Motor Neuron Diseases Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Motor Neuron Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Motor Neuron Diseases Treatment Market Share by Application (2015-2020)
Table 77. NIH Company Details
Table 78. NIH Business Overview
Table 79. NIH Product
Table 80. NIH Revenue in Motor Neuron Diseases Treatment Business (2015-2020) (Million US$)
Table 81. NIH Recent Development
Table 82. UCL Institute of Neurology Company Details
Table 83. UCL Institute of Neurology Business Overview
Table 84. UCL Institute of Neurology Product
Table 85. UCL Institute of Neurology Revenue in Motor Neuron Diseases Treatment Business (2015-2020) (Million US$)
Table 86. UCL Institute of Neurology Recent Development
Table 87. National Neuroscience Institute Company Details
Table 88. National Neuroscience Institute Business Overview
Table 89. National Neuroscience Institute Product
Table 90. National Neuroscience Institute Revenue in Motor Neuron Diseases Treatment Business (2015-2020) (Million US$)
Table 91. National Neuroscience Institute Recent Development
Table 92. The University of Melbourne Company Details
Table 93. The University of Melbourne Business Overview
Table 94. The University of Melbourne Product
Table 95. The University of Melbourne Revenue in Motor Neuron Diseases Treatment Business (2015-2020) (Million US$)
Table 96. The University of Melbourne Recent Development
Table 97. The University of Sheffield Company Details
Table 98. The University of Sheffield Business Overview
Table 99. The University of Sheffield Product
Table 100. The University of Sheffield Revenue in Motor Neuron Diseases Treatment Business (2015-2020) (Million US$)
Table 101. The University of Sheffield Recent Development
Table 102. OZBiosciences Company Details
Table 103. OZBiosciences Business Overview
Table 104. OZBiosciences Product
Table 105. OZBiosciences Revenue in Motor Neuron Diseases Treatment Business (2015-2020) (Million US$)
Table 106. OZBiosciences Recent Development
Table 107. The University of Queensland Company Details
Table 108. The University of Queensland Business Overview
Table 109. The University of Queensland Product
Table 110. The University of Queensland Revenue in Motor Neuron Diseases Treatment Business (2015-2020) (Million US$)
Table 111. The University of Queensland Recent Development
Table 112. MND Australia Business Overview
Table 113. MND Australia Product
Table 114. MND Australia Company Details
Table 115. MND Australia Revenue in Motor Neuron Diseases Treatment Business (2015-2020) (Million US$)
Table 116. MND Australia Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Motor Neuron Diseases Treatment Market Share by Type: 2020 VS 2026
Figure 2. Riluzole Features
Figure 3. Nusinersen Features
Figure 4. Physical Therapy Features
Figure 5. Respiratory Therapy Features
Figure 6. Others Features
Figure 7. Global Motor Neuron Diseases Treatment Market Share by Application: 2020 VS 2026
Figure 8. Multidisciplinary Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Social Work Facilities Case Studies
Figure 11. Others Case Studies
Figure 12. Motor Neuron Diseases Treatment Report Years Considered
Figure 13. Global Motor Neuron Diseases Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Motor Neuron Diseases Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Motor Neuron Diseases Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Motor Neuron Diseases Treatment Market Share by Players in 2019
Figure 18. Global Top Motor Neuron Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motor Neuron Diseases Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Motor Neuron Diseases Treatment Revenue in 2019
Figure 20. North America Motor Neuron Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Motor Neuron Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Motor Neuron Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Motor Neuron Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Motor Neuron Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Motor Neuron Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Motor Neuron Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
豚病治療の世界市場（～2026年） Swine diseases treatments help in improving health, increase production of livestock and prevent transmission of diseases among animals in a cost effective manner. The global swine diseases treatment market is driven by factors such as rapid changing pattern of diseases among the animals. Market Ana…- 筋骨格系疾患治療の世界市場（～2026年） Musculoskeletal disorders (MSDs) are injuries or pain in the human musculoskeletal system, including the joints, ligaments, muscles, nerves, tendons, and structures that support limbs, neck and back. MSDs can arise from a sudden exertion (e.g., lifting a heavy object)[2], or they can arise from maki…
- 希少性肺疾患治療の世界市場（～2026年） Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are e…
- 免疫介在性炎症性疾患治療の世界市場（～2026年） Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…
- 慢性肺疾患治療の世界市場（～2026年） Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…